Ethylisopropyllysergamide

Chemical compound related to LSD

Chemical Compound
Identifiers
CAS Number
PubChem CID
ChemSpider ID
UNII
ChEBI
ChEMBL
Properties
Chemical Formula
Molar Mass
Appearance
Density
Melting Point
Boiling Point
Hazards
GHS Pictograms	[[File:|50px]]
GHS Signal Word
GHS Hazard Statements
NFPA 704	[[File:|50px]]
References

Ethylisopropyllysergamide (EiPLA) is a chemical compound that belongs to the class of lysergamides, which are derivatives of lysergic acid. It is structurally related to the well-known psychedelic LSD (lysergic acid diethylamide) and is part of a group of compounds known as lysergamide analogs.

Chemical Structure and Properties

Ethylisopropyllysergamide is characterized by the substitution of the diethylamide group in LSD with an ethylisopropylamide group. This modification results in a compound with the chemical formula C₂₀H₂₇N₃O. The molecular structure of EiPLA includes a lysergic acid core, which is a tetracyclic ergoline derivative, and an amide group that is essential for its activity.

Chemical structure of Ethylisopropyllysergamide

Pharmacology

The pharmacological effects of Ethylisopropyllysergamide are not well-documented, but it is believed to act as a partial agonist at the 5-HT_2A receptor, similar to other lysergamides. This receptor is primarily responsible for the psychedelic effects of compounds like LSD. The binding affinity and efficacy of EiPLA at various serotonin receptors have not been extensively studied, and its psychoactive potency relative to LSD is not well established.

Synthesis

The synthesis of Ethylisopropyllysergamide involves the reaction of lysergic acid with ethylisopropylamine. This process is similar to the synthesis of other lysergamides, where the amide group is introduced through an amide bond formation. The synthesis requires careful control of reaction conditions to ensure the correct stereochemistry and purity of the final product.

Legal Status

The legal status of Ethylisopropyllysergamide varies by country. In some jurisdictions, it may be considered a controlled substance due to its structural similarity to LSD, which is a Schedule I controlled substance in many countries. However, specific regulations regarding EiPLA may not be explicitly defined, leading to its classification as a "research chemical" in some areas.

Potential Uses and Research

Research into Ethylisopropyllysergamide is limited, and its potential uses are largely speculative. As a lysergamide, it may have applications in the study of psychedelic therapy and the exploration of consciousness. However, due to the lack of comprehensive studies, its safety profile and therapeutic potential remain unknown.

Related Pages

• Lysergic acid diethylamide
• Lysergic acid
• Psychedelic drug
• Serotonin receptor